Related Experiment Video
Updated: Nov 21, 2025

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
Essential Hypertension Worsens Left Ventricular Contractility in Systemic Sclerosis
Valentina Mercurio1, Alicia M Hinze2, Laura K Hummers3
1V. Mercurio, MD, PhD, Assistant Professor of Medicine, University of Naples Federico II, Department of Translational Medical Sciences, and Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine.
Insights
Systemic sclerosis (SSc) patients have reduced heart contractility, even without hypertension. Essential hypertension further worsens this subclinical cardiac dysfunction in SSc patients.
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Background:
- Primary cardiac involvement is common and serious in systemic sclerosis (SSc).
- The impact of traditional cardiovascular risk factors like essential hypertension (HTN) on cardiac function in SSc is not well understood.
Purpose of the Study:
- To investigate the effects of essential hypertension (HTN) on left ventricular (LV) contractility in patients with SSc.
- To utilize echocardiography-derived global longitudinal strain (GLS) to assess LV contractility.
Main Methods:
- Compared 56 SSc patients with HTN (SSc+HTN+) and 82 SSc patients without HTN (SSc+HTN-) to 40 hypertensive (SSc-HTN+) and 40 non-hypertensive (SSc-HTN-) controls.
- Assessed LV ejection fraction (LVEF), left atrial volume index (LAVI), LV diastolic function, and LV contractility via GLS.
Main Results:
- SSc patients exhibited diminished GLS compared to controls, irrespective of HTN status, despite normal LVEF.
- SSc+HTN+ patients showed the highest prevalence of diastolic dysfunction and the most significant reduction in GLS.
Conclusions:
- Subclinical LV contractile dysfunction is present in SSc, even with normal LVEF.
- Concomitant HTN exacerbates LV dysfunction and diastolic impairment in SSc patients.
- HTN is a critical, modifiable cardiovascular risk factor requiring aggressive management in SSc.
Objective:
Primary cardiac involvement in systemic sclerosis (SSc) is prevalent and morbid; however, the influence of traditional cardiovascular (CV) risk factors, such as essential hypertension (HTN), are unclear. In the present study, we sought to understand the effects of HTN on left ventricular (LV) contractility in patients with SSc using echocardiographic speckle-derived global longitudinal strain (GLS).
Methods:
Fifty-six SSc patients with HTN (SSc+HTN+) and 82 SSc patients without HTN (SSc+ HTN-) were compared with 40 non-SSc controls with HTN (SSc-HTN+) and 40 non-SSc controls without HTN (SSc-HTN-), matched by age and sex. All HTN patients were on stable antihypertensive therapies. Echocardiographic measures included LV (LV) ejection fraction (LVEF), left atrial volume index (LAVI), and LV diastolic function. LV contractility was assessed by GLS, averaged across the 18 LV segments.
Results:
Patients with SSc had diminished GLS regardless of HTN status when compared to both control groups, despite normal LVEF (P < 0.001). SSc+HTN+ had the highest prevalence of diastolic dysfunction, with significantly higher septal E/e´, a marker of LV filling pressures (P < 0.05), as well as the largest reduction in GLS compared to SSc+HTN- and both control groups.
Conclusion:
Speckle-derived strain revealed diminished LV contractility in patients with SSc, despite normal LVEF. SSc+HTN+ had more prominent reductions in GLS associated with evidence of LV remodeling and worsened diastolic function. Our findings demonstrate the presence of subclinical LV contractile dysfunction in SSc that is further exacerbated by concomitant HTN, thereby identifying HTN as an important modifiable CV risk factor that should be managed aggressively in this at-risk population.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Mitral Regurgitation I: Introduction
Pathophysiology of Heart Failure
Hypertension II: Pathophysiology
Heart Failure III: Clinical Manifestations

